Live Breaking News & Updates on Mutlay sayan

Stay informed with the latest breaking news from Mutlay sayan on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mutlay sayan and stay connected to the pulse of your community

What is Prostate-Specific Antigen and Why Is It Important For Patients with Prostate Cancer?

Checking PSA levels following treatment is crucial among patients with nonmetastatic, unfavorable risk prostate cancer, according to the co-author of a recent study.

United-states , Boston , Massachusetts , Dana-farber-cancer-institute , American , Mutlay-sayan , Harvard-medical-school , American-cancer-society , American-cancer , News , Prostate-cancer ,

Quicker PSA Recurrence, Failure Factors in Patients with Prostate Cancer Identified

Recent research has put a spotlight on a number of factors which could be used to estimate which patients with nonmetastatic, unfavorable-risk prostate cancer are at high risk for a shorter time until PSA recurrence and failure.

Mutlay-sayan , Harvard-medical-school , Dana-farber-cancer-institute , Prostate-cancer ,

Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer

Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Dana-farber-cancer-institute , Massachusetts , United-states , Martinw-schoen , Mutlay-sayan , Sciencex-network , Cumulative-incidence-curves , Short-term-prostate-specific-antigen-recurrence , Patients-with-prostate-cancer , Recurrence-after-radiation , Early-prostate-cancer , Risk-stratification-from-prospective-trials

These Factors Predict Shorter Time to PSA Failure

A new study identifies three factors associated with PSA failure in men with nonmetastatic unfavorable-risk prostate cancer, revealing who may benefit from treatment escalation.

Dana-farber-cancer-institute , Massachusetts , United-states , Boston , Martin-schoen , Mutlay-sayan , Charles-bennett , Prostate-carcinoma , Alignant-prostate-neoplasm , Rostate-cancer , Ancer-prostate- , Cancer